Abiopharma

Global Ship Lease Announces Results of 2026 Annual Meeting of Shareholders

Office Properties Income Trust Completes Chapter 11 Reorganization

Odyssey Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 2 at SLEEP 2026

First Horizon Corporation to Announce Second Quarter Financial Results on July 15, 2026

TechnipFMC Announces Second-Quarter 2026 Earnings Release and Conference Call

ADT Joins Board of Directors of the Connectivity Standards Alliance, Reinforcing Its Role in Shaping the Future of the Connected Home

National Healthcare Properties Announces Preliminary Results of its Series A and Series B Preferred Stock Self Tender Offers

Rumble Closes Acquisition of Northern Data